SCHNEYER MARK C. (Chief Financial Officer) sold 4.1% of their position (2.71K shares) of ACADIA PHARMACEUTICALS INC on the open market
Open‑market sale worth $60.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/7/2026ACC: 0001899977-26-000005
Officer· Chief Financial Officer
Since Dec 2021
-2.71K
Net shares
Net seller
$60.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
5.28K acquired · 7.99K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5.28K
Price / share
—
Trade value
—
% of position
8.8%
4/5/2026
60.27K→65.55K
Common Stock
Direct
Shares
−2.71K
Price / share
$22.20
Trade value
$60.14K
% of position
4.1%
4/7/2026
65.55K→62.84K
Total
Net shares
+2.57K
Net value
-$60.14K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/5/2026 | M · Option Exercise | +5.28K | — | — | 8.8% | 60.27K | 65.55K |
| Common Stock Direct | 4/7/2026 | S · Sale | −2.71K | $22.20 | $60.14K | 4.1% | 65.55K | 62.84K |
| Total | +2.57K | -$60.14K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
5.28K shares
Shares
−5.28K
Strike price
Held after
0.00
Exercisable
—
4/5/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock5.28K shares | 4/5/2026 | M · Option Exercise | −5.28K | — | 0.00 |